{"id":339749,"date":"2026-11-04T21:42:16","date_gmt":"2026-11-04T16:12:16","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/shukra-pharmaceuticals-q2-results-fy27-pat-13-crore\/"},"modified":"2026-11-04T21:42:16","modified_gmt":"2026-11-04T16:12:16","slug":"shukra-pharmaceuticals-q2-results-fy27-pat-13-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/shukra-pharmaceuticals-q2-results-fy27-pat-13-crore\/","title":{"rendered":"Shukra Pharmaceuticals Q2 Results FY27: Profit Jumps 434.03% to Rs 12.71 Cr, Revenue Rs 44.20 Cr, PAT Rs 12.71 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Shukra Pharmaceuticals Q2 Results FY27 were declared on 4 November 2026 on a Consolidated basis, showing revenue of Rs 44.20 Cr against Rs 5.88 Cr a year earlier. The YoY growth figure for revenue is 651.7%, while net profit of Rs 12.71 Cr compares with Rs 2.38 Cr, a rise of 434.03%. These quarterly results cover July to September 2026.<\/p>\n<\/div>\n

Shukra Pharmaceuticals Ltd (SHUKRAPHAR) Q2 Results FY27 announced on 4 November 2026, covering the company’s financial performance for the July to September quarter. The results date brings consolidated results showing revenue of Rs 44.20 Cr and net profit of Rs 12.71 Cr, and Shukra Pharmaceuticals Q2 Results FY27 anchor every figure in this article. Univest follows the filing on NSE and BSE.<\/p>\n

This Shukra Pharmaceuticals Q2 Results results analysis covers the financial highlights, the business factors on record, the outlook and the risks that investors can verify. It opens with the Financial Highlights table, which sets the latest quarter beside the same quarter of last year.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n